Novogene Europe

About Novogene Europe

Novogene Europe is a leading provider of genomic services and solutions, dedicated to advancing the field of genomics through innovative technologies and comprehensive support. Established as a subsidiary of Novogene Corporation, we leverage cutting-edge sequencing technology to deliver high-quality genomic data for research and clinical applications.

Our core activities include whole genome sequencing, targeted sequencing, RNA sequencing, and bioinformatics analysis. We cater to a diverse clientele, including academic institutions, pharmaceutical companies, and healthcare providers, ensuring that they have access to the most accurate and reliable genomic information.

At Novogene Europe, we are committed to enhancing the understanding of genetic variations and their implications in health and disease. Our team of experts works closely with clients to provide tailored solutions that meet their specific research needs.

We pride ourselves on our state-of-the-art laboratory facilities, which are equipped with the latest sequencing technologies and adhere to the highest quality standards. Our commitment to excellence is reflected in our rigorous quality control processes and our dedication to continuous improvement.

In addition to our technical capabilities, we offer comprehensive support services, including consultation, project design, and data interpretation. Our goal is to empower researchers and clinicians with the tools and insights they need to make informed decisions based on genomic data.

As we look to the future, Novogene Europe aims to expand its reach and impact in the genomics field, fostering collaborations and partnerships that drive innovation and discovery. We believe that by working together, we can unlock the full potential of genomics to improve human health and advance scientific knowledge.

Join us on our journey to revolutionise genomics and contribute to a healthier future for all.